Results 91 to 100 of about 17,390 (200)
Harnessing the Potential of mRNA Vaccines Against Infectious Diseases
Microbial Biotechnology, Volume 18, Issue 8, August 2025.RNA vaccines are promising because of their flexible design, strong immunogenicity, safety and rapid development. Recent advances have enabled mRNA vaccines to target various pathogens, including viruses such as influenza and HIV, bacteria such as Mycobacteria and Pseudomonas aeruginosa, and parasites such as those causing malaria.
Nouran Rezk, Siobhán McClean
wiley +1 more source
Post-Ebola Measles Outbreak in Lola, Guinea, January–June 2015
Emerging Infectious Diseases, 2016 During public health crises such as the recent outbreaks of Ebola virus disease in West Africa, breakdowns in public health systems can lead to epidemics of vaccine-preventable diseases. We report here on an outbreak of measles in the prefecture of Lola,
Jonathan E. Suk +14 more
doaj +1 more source
A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection. [PDF]
, 2017 Asymptomatic ebolavirus infection could greatly influence transmission dynamics, but there is little consensus on how frequently it occurs or even if it exists. This paper summarises the available evidence on seroprevalence of Ebola, Sudan and Bundibugyo
Bower, Hilary, Glynn, Judith R
core +2 more sources
Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease
Emerging Infectious Diseases, 2014 Outbreaks of Ebola virus disease (EVD) occur sporadically in Africa and are associated with high case-fatality rates. Historically, children have been less affected than adults.
Anita K. McElroy +6 more
doaj +1 more source
Emergence of Lassa Fever Disease in Northern Togo: Report of Two Cases in Oti District in 2016
Case Reports in Infectious Diseases, 2017 Background. Lassa fever belongs to the group of potentially fatal hemorrhagic fevers, never reported in Togo. The aim of this paper is to report the first two cases of Lassa fever infection in Togo. Case Presentation.
Akouda Akessiwe Patassi +14 more
doaj +1 more source
Mapping the zoonotic niche of Marburg virus disease in Africa. [PDF]
, 2015 BACKGROUND: Marburg virus disease (MVD) describes a viral haemorrhagic fever responsible for a number of outbreaks across eastern and southern Africa. It is a zoonotic disease, with the Egyptian rousette (Rousettus aegyptiacus) identified as a reservoir ...
Brady, Oliver J +7 more
core +2 more sources
Ebola virus disease: Essential clinical knowledge
Avicenna Journal of Medicine, 2017 Since its initial outbreak in 1976, Ebola virus disease (EVD) has affected thousands of people, causing severe illness with high mortality rates. In the absence of a vaccine or effective specific treatment, as well as the lack of early diagnostic and ...
Mahmoud Tawfik Khalafallah +3 more
doaj +1 more source
Convalescent plasma. New evidence for an old therapeutic tool? [PDF]
, 2016 Passive immunisation for the prevention and treatment of human infectious diseases can be traced back to the 20th century. The recent Ebola virus outbreak in West Africa has turned the spotlight onto the possible use of convalescent whole blood and ...
Catalano, Liviana +6 more
core +1 more source
Ebola Hemorrhagic Fever: Genetic Biomarkers and Vaccine Development [PDF]
Genetic Testing and Molecular Biomarkers, 2014 The Ebola virus causes a highly virulent systemic disease that involves viral hemorrhagic fever, affects multiple organ systems, and leads to internal bleeding and, in most cases, death. The World Health Organization estimates that as of August 31, 2014, there have been 3,685 cases and 1,841 deaths during the current outbreak (World Health Organization,
openaire +2 more sources
Journal of Infection and Public Health, 2017 Summary: Ebola hemorrhagic fever (EHF) is an emerging threat to public health. The last epidemic in West Africa had a great effect on the affected communities.
Mohamed M.G. Mohamed +6 more
doaj +1 more source